Jefferson Capital price target lowered to $22 from $25 at Raymond James

Raymond James lowered the firm’s price target on Jefferson Capital (JCAP) to $22 from $25 and keeps an Outperform rating on the shares. Despite reducing its price target the firm continues to believe Jefferson’s lower leverage, efficient collection model, heavy exposure to the U.S. market, which the firm believes is “currently more attractive,” and recent acquisition of Blue Stem “position Jefferson Capital to outperform in the medium term.”